Crosstalk between epithelial sodium channels (ENaC) and basolateral potassium channels (Kir4.1/Kir5.1) in the cortical collecting duct. (7th February 2022)
- Record Type:
- Journal Article
- Title:
- Crosstalk between epithelial sodium channels (ENaC) and basolateral potassium channels (Kir4.1/Kir5.1) in the cortical collecting duct. (7th February 2022)
- Main Title:
- Crosstalk between epithelial sodium channels (ENaC) and basolateral potassium channels (Kir4.1/Kir5.1) in the cortical collecting duct
- Authors:
- Isaeva, Elena
Bohovyk, Ruslan
Fedoriuk, Mykhailo
Shalygin, Alexey
Klemens, Christine A.
Zietara, Adrian
Levchenko, Vladislav
Denton, Jerod S.
Staruschenko, Alexander
Palygin, Oleg - Other Names:
- Stefanska Barbara guestEditor.
Tucker Steven guestEditor.
MacEwan David guestEditor. - Abstract:
- Abstract : Background and Purpose: Inwardly rectifying K + (Kir ) channels located on the basolateral membrane of epithelial cells of the distal nephron play a crucial role in K + handling and BP control, making these channels an attractive target for the treatment of hypertension. The purpose of the present study was to determine how the inhibition of basolateral Kir 4.1/Kir 5.1 heteromeric K + channel affects epithelial sodium channel (ENaC)‐mediated Na + transport in the principal cells of cortical collecting duct (CCD). Experimental Approach: The effect of fluoxetine, amitriptyline and recently developed Kir inhibitor, VU0134992, on the activity of Kir 4.1, Kir 4.1/Kir 5.1 and ENaC were tested using electrophysiological approaches in CHO cells transfected with respective channel subunits, cultured polarized epithelial mCCDcl1 cells and freshly isolated rat and human CCD tubules. To test the effect of pharmacological Kir 4.1/Kir 5.1 inhibition on electrolyte homeostasis in vivo and corresponding changes in distal tubule transport, Dahl salt‐sensitive rats were injected with amitriptyline (15 mg·kg −1 ·day −1 ) for 3 days. Key Results: We found that inhibition of Kir 4.1/Kir 5.1, but not the Kir 4.1 channel, depolarizes the cell membrane, induces the elevation of intracellular Ca 2+ concentration and suppresses ENaC activity. Furthermore, we demonstrate that amitriptyline administration leads to a significant drop in plasma K + level, triggering sodium excretion andAbstract : Background and Purpose: Inwardly rectifying K + (Kir ) channels located on the basolateral membrane of epithelial cells of the distal nephron play a crucial role in K + handling and BP control, making these channels an attractive target for the treatment of hypertension. The purpose of the present study was to determine how the inhibition of basolateral Kir 4.1/Kir 5.1 heteromeric K + channel affects epithelial sodium channel (ENaC)‐mediated Na + transport in the principal cells of cortical collecting duct (CCD). Experimental Approach: The effect of fluoxetine, amitriptyline and recently developed Kir inhibitor, VU0134992, on the activity of Kir 4.1, Kir 4.1/Kir 5.1 and ENaC were tested using electrophysiological approaches in CHO cells transfected with respective channel subunits, cultured polarized epithelial mCCDcl1 cells and freshly isolated rat and human CCD tubules. To test the effect of pharmacological Kir 4.1/Kir 5.1 inhibition on electrolyte homeostasis in vivo and corresponding changes in distal tubule transport, Dahl salt‐sensitive rats were injected with amitriptyline (15 mg·kg −1 ·day −1 ) for 3 days. Key Results: We found that inhibition of Kir 4.1/Kir 5.1, but not the Kir 4.1 channel, depolarizes the cell membrane, induces the elevation of intracellular Ca 2+ concentration and suppresses ENaC activity. Furthermore, we demonstrate that amitriptyline administration leads to a significant drop in plasma K + level, triggering sodium excretion and diuresis. Conclusion and Implications: The present data uncover a specific role of the Kir 4.1/Kir 5.1 channel in the modulation of ENaC activity and emphasize the potential for using Kir 4.1/Kir 5.1 inhibitors to regulate electrolyte homeostasis and BP. … (more)
- Is Part Of:
- British journal of pharmacology. Volume 179:Number 12(2022)
- Journal:
- British journal of pharmacology
- Issue:
- Volume 179:Number 12(2022)
- Issue Display:
- Volume 179, Issue 12 (2022)
- Year:
- 2022
- Volume:
- 179
- Issue:
- 12
- Issue Sort Value:
- 2022-0179-0012-0000
- Page Start:
- 2953
- Page End:
- 2968
- Publication Date:
- 2022-02-07
- Subjects:
- amitriptyline -- ENaC -- hypokalaemia -- Kcnj10 -- Kcnj16 -- Kir (IRK) channels
Pharmacology -- Periodicals
Chemotherapy -- Periodicals
Drug Therapy -- Periodicals
Pharmacology -- Periodicals
615.1 - Journal URLs:
- http://bibpurl.oclc.org/web/21844 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1476-5381/issues ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=282&action=archive ↗
http://onlinelibrary.wiley.com/ ↗
http://www.nature.com/bjp/index.html ↗ - DOI:
- 10.1111/bph.15779 ↗
- Languages:
- English
- ISSNs:
- 0007-1188
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2314.700000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 21476.xml